Publication date: Jul 20, 2026
Anosmia/hyposmia affected 14. 8%-19. 6% of participants in the UK and the USA in the post-pandemic era. Since symptom onset, 37. 1%-48. 8% of affected participants reported no improvement, while 15. 3%-17. 6% reported worsening symptoms. Anosmia/hyposmia remains strongly associated with reduced quality of life across both countries. Among respondents reporting anosmia or hyposmia, a high proportion (88. 8%-93. 5%) also experienced concurrent parosmia.
| Concepts | Keywords |
|---|---|
| COVID‐19 | |
| quality of life |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Taste Disorders |
| disease | MESH | COVID-19 Pandemic |
| disease | MESH | Anosmia |
| disease | MESH | parosmia |
Original Article
(Visited 7 times, 1 visits today)